Search

Tony Michael Argenbright

Examiner (ID: 16324)

Most Active Art Unit
3402
Art Unit(s)
3402, 3747
Total Applications
2731
Issued Applications
2589
Pending Applications
40
Abandoned Applications
102

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6134874 [patent_doc_number] => 20110008762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Methods for Preserving Organs and Tissues' [patent_app_type] => utility [patent_app_number] => 12/727637 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11432 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008762.pdf [firstpage_image] =>[orig_patent_app_number] => 12727637 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/727637
Methods for preserving organs and tissues Mar 18, 2010 Issued
Array ( [id] => 6639592 [patent_doc_number] => 20100174048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Processes for Preparing a Polypeptide' [patent_app_type] => utility [patent_app_number] => 12/727758 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11997 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0174/20100174048.pdf [firstpage_image] =>[orig_patent_app_number] => 12727758 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/727758
Processes for Preparing a Polypeptide Mar 18, 2010 Abandoned
Array ( [id] => 6571294 [patent_doc_number] => 20100234566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Processes for Preparing a Polypeptide' [patent_app_type] => utility [patent_app_number] => 12/727653 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12166 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234566.pdf [firstpage_image] =>[orig_patent_app_number] => 12727653 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/727653
Processes for Preparing a Polypeptide Mar 18, 2010 Abandoned
Array ( [id] => 6566446 [patent_doc_number] => 20100234272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Processes for Preparing a Polypeptide' [patent_app_type] => utility [patent_app_number] => 12/726571 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12163 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234272.pdf [firstpage_image] =>[orig_patent_app_number] => 12726571 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/726571
Processes for preparing a polypeptide Mar 17, 2010 Issued
Array ( [id] => 7744225 [patent_doc_number] => 20120021969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'PROSTHETIC IMPLANT SHELL' [patent_app_type] => utility [patent_app_number] => 13/254393 [patent_app_country] => US [patent_app_date] => 2010-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4039 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021969.pdf [firstpage_image] =>[orig_patent_app_number] => 13254393 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/254393
PROSTHETIC IMPLANT SHELL Mar 2, 2010 Abandoned
Array ( [id] => 7651805 [patent_doc_number] => 20110301074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'PROTEIN PREPARATION PRODUCED FROM RAPE SEEDS' [patent_app_type] => utility [patent_app_number] => 13/201480 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8855 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301074.pdf [firstpage_image] =>[orig_patent_app_number] => 13201480 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/201480
Protein preparation produced from rape seeds Feb 25, 2010 Issued
Array ( [id] => 6532400 [patent_doc_number] => 20100221341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Alanine-Based Peptide Hydrogels' [patent_app_type] => utility [patent_app_number] => 12/713820 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 7361 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221341.pdf [firstpage_image] =>[orig_patent_app_number] => 12713820 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/713820
Alanine-Based Peptide Hydrogels Feb 25, 2010 Abandoned
Array ( [id] => 10121433 [patent_doc_number] => 09155780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Short beta-defensin-derived peptides' [patent_app_type] => utility [patent_app_number] => 13/148376 [patent_app_country] => US [patent_app_date] => 2010-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 22 [patent_no_of_words] => 18461 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13148376 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/148376
Short beta-defensin-derived peptides Feb 9, 2010 Issued
Array ( [id] => 6137742 [patent_doc_number] => 20110009669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'ABUSE-RESISTANT AMPHETAMINE PRODRUGS' [patent_app_type] => utility [patent_app_number] => 12/701483 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 42263 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009669.pdf [firstpage_image] =>[orig_patent_app_number] => 12701483 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/701483
ABUSE-RESISTANT AMPHETAMINE PRODRUGS Feb 4, 2010 Abandoned
Array ( [id] => 7791666 [patent_doc_number] => 20120053222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'Novel Metabolic Disease Therapy' [patent_app_type] => utility [patent_app_number] => 13/145906 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 14444 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053222.pdf [firstpage_image] =>[orig_patent_app_number] => 13145906 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/145906
Novel Metabolic Disease Therapy Jan 21, 2010 Abandoned
Array ( [id] => 7685442 [patent_doc_number] => 20100120699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'METHOD FOR SYNTHESIZING KPV TRIPEPTIDE DIAMIDE DERIVATES' [patent_app_type] => utility [patent_app_number] => 12/692141 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9821 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120699.pdf [firstpage_image] =>[orig_patent_app_number] => 12692141 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/692141
METHOD FOR SYNTHESIZING KPV TRIPEPTIDE DIAMIDE DERIVATES Jan 21, 2010 Abandoned
Array ( [id] => 7587285 [patent_doc_number] => 20110281795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/146220 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20700 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281795.pdf [firstpage_image] =>[orig_patent_app_number] => 13146220 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/146220
GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Jan 14, 2010 Abandoned
Array ( [id] => 7685451 [patent_doc_number] => 20100120690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Polypeptides Having Antimicrobial Activity and Polynucleotides Encoding Same' [patent_app_type] => utility [patent_app_number] => 12/687267 [patent_app_country] => US [patent_app_date] => 2010-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25241 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120690.pdf [firstpage_image] =>[orig_patent_app_number] => 12687267 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/687267
Polypeptides Having Antimicrobial Activity and Polynucleotides Encoding Same Jan 13, 2010 Abandoned
Array ( [id] => 4624302 [patent_doc_number] => 08003598 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Peptide anti-tumor agent' [patent_app_type] => utility [patent_app_number] => 12/647899 [patent_app_country] => US [patent_app_date] => 2009-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8648 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003598.pdf [firstpage_image] =>[orig_patent_app_number] => 12647899 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/647899
Peptide anti-tumor agent Dec 27, 2009 Issued
Array ( [id] => 7663629 [patent_doc_number] => 20110312898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER' [patent_app_type] => utility [patent_app_number] => 13/142414 [patent_app_country] => US [patent_app_date] => 2009-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 58985 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312898.pdf [firstpage_image] =>[orig_patent_app_number] => 13142414 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/142414
PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER Dec 27, 2009 Abandoned
Array ( [id] => 7490058 [patent_doc_number] => 20110237493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'DIPEPTIDE LINKED MEDICINAL AGENTS' [patent_app_type] => utility [patent_app_number] => 13/130963 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28474 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237493.pdf [firstpage_image] =>[orig_patent_app_number] => 13130963 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/130963
DIPEPTIDE LINKED MEDICINAL AGENTS Dec 17, 2009 Abandoned
Array ( [id] => 6295260 [patent_doc_number] => 20100160230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'UBIQUITIN AND UBIQUITIN RELATED MOLECULES FOR TREATMENT AND PREVENTION OF HARMFUL ACTIVATION OF THE IMMUNE SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/642219 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12033 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160230.pdf [firstpage_image] =>[orig_patent_app_number] => 12642219 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/642219
UBIQUITIN AND UBIQUITIN RELATED MOLECULES FOR TREATMENT AND PREVENTION OF HARMFUL ACTIVATION OF THE IMMUNE SYSTEM Dec 17, 2009 Abandoned
Array ( [id] => 6492333 [patent_doc_number] => 20100093605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'PEPTIDES, DERIVATIVES AND ANALOGS THEREOF, AND METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 12/635053 [patent_app_country] => US [patent_app_date] => 2009-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26613 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093605.pdf [firstpage_image] =>[orig_patent_app_number] => 12635053 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/635053
Peptides, derivatives and analogs thereof, and methods of using same Dec 9, 2009 Issued
Array ( [id] => 6499201 [patent_doc_number] => 20100215583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'CELL NUCLEUS-ENTERING COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/632654 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10204 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215583.pdf [firstpage_image] =>[orig_patent_app_number] => 12632654 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/632654
CELL NUCLEUS-ENTERING COMPOSITIONS Dec 6, 2009 Abandoned
Array ( [id] => 6453768 [patent_doc_number] => 20100105606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'METHODS FOR MAKING HIGH OXYGEN AFFINITY MODIFIED HEMOGLOBIN FOR OXYGEN TRANSPORT' [patent_app_type] => utility [patent_app_number] => 12/625900 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12503 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105606.pdf [firstpage_image] =>[orig_patent_app_number] => 12625900 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/625900
Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin Nov 24, 2009 Issued
Menu